SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-032126
Filing Date
2019-08-14
Accepted
2019-08-14 16:01:29
Documents
63
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stok-10q_20190630.htm 10-Q 1883085
2 EX-3.1 stok-ex31_114.htm EX-3.1 48227
3 EX-3.2 stok-ex32_115.htm EX-3.2 282416
4 EX-31.1 stok-ex311_455.htm EX-31.1 15921
5 EX-31.2 stok-ex312_456.htm EX-31.2 15967
6 EX-32.1 stok-ex321_453.htm EX-32.1 7181
7 EX-32.2 stok-ex322_454.htm EX-32.2 7880
  Complete submission text file 0001564590-19-032126.txt   5580961

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT stok-20190630.xml EX-101.INS 909019
9 XBRL TAXONOMY EXTENSION SCHEMA stok-20190630.xsd EX-101.SCH 43364
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stok-20190630_cal.xml EX-101.CAL 31095
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stok-20190630_def.xml EX-101.DEF 117023
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20190630_lab.xml EX-101.LAB 299670
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20190630_pre.xml EX-101.PRE 232216
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38938 | Film No.: 191026078
SIC: 2834 Pharmaceutical Preparations